FIELD: biochemistry, biotechnology, peptides.
SUBSTANCE: invention relates to protein of molecular mass 12000 Da isolated from medicinal leech saliva (Hirudo medicinalis) comprising 6 cysteine residues able to form bonds -S-S-, and pI value about 3.7. The novel protein possesses ability to block platelets adhesion induced by collagen. As result of screening cDNA library of H. medicinalis a novel gene of new inhibitor of adhesion is identified and its nucleotide sequence is determined. Invention describes a method for preparing recombinant form of protein involving transformation of suitable cells with vector comprising DNA sequence encoding inhibitor, culturing cells under condition providing its expression and isolation of expressed protein. Invention proposes using natural and recombinant forms of inhibitor in therapy states associated with vessels congestion and diseases of circulatory system, and for treatment of articles surface made of natural and artificial collagen.
EFFECT: valuable biological and medicinal properties of polypeptide.
17 cl, 10 dwg, 13 ex
Title |
Year |
Author |
Number |
NOVEL SPECIFIC MECHANISM FOR INHIBITION OF PLATELET ADHESION TO COLLAGEN |
2001 |
- Kristofer Barnes
- Mattias Frekh
- Uve Khofmann
- Iogannes Glajtts
- Vol'Fgang Shtrittmatter
|
RU2302880C2 |
PROTEIN INHIBITING COLLAGEN-CAUSED AGGREGATION OF MAMMALIAN PLATELETS, RECOMBINANT PROTEIN INHIBITING COLLAGEN-CAUSED AGGREGATION OF PLATELETS, DNA FRAGMENT ENCODING RECOMBINANT PROTEIN, EXPRESSION VECTOR (VARIANTS), STRAIN OF CULTURED MAMMALIAN CELLS BHK - PRODUCER OF RECOMBINANT PROTEIN (VARIANTS), METHOD OF PREPARING RECOMBINANT PROTEIN, PHARMACEUTICAL COMPOSITION |
1992 |
- Kristiane Neske-Jungblut
- Bernkhard Khehndler
- Jern Krehttsshmar
- Vol'F-Diter Shlojning
- Alekhandro Alagon
- Lurival' Domingos Possani
- Delia Anatolia Kevas-Agirre
|
RU2128705C1 |
PROTEIN CAPABLE ON INHIBITING COLLAGEN STIMULATED AGGREGATION OF THROMBOCYTES AND PREVENTING INTERACTION BETWEEN COLLAGEN AND vWF, METHOD OF PREPARING THEREOF, PHARMACOLOGICAL COMPOSITION BASED THEREON |
1994 |
- Jurgen Khemberger
- Gvido Mel'Tser
|
RU2160280C2 |
POLYPEPTIDE, POSSESSING INHIBITING ACTIVITY WITH RESPECT TO PLATELET AGGREGATION AND/OR INHIBITING ACTIVITY WITH RESPECT TO PLATELET ADHESION, ENCODING IT POLYNUCLEOTIDE, COMPOSITION AND SET, CONTAINING SAID POLYPEPTIDE |
2006 |
|
RU2434941C2 |
COMPOSITION, INHIBITING PLATELET AGGREGATION |
2006 |
- Josida, Sigeto
- Sudo, Tosiki
|
RU2557296C2 |
RECOMBINANT PROTEIN ASP-PALLIDIPIN, METHOD OF ITS PRODUCTION AND PURIFICATION, VECTOR, STRAIN, PHARMACEUTICAL COMPOSITION |
1995 |
- Noeske-Jungblut Kristiane
- Beker Andreas
- Khendler Bernard
|
RU2186110C2 |
NATURAL AND RECOMBINANT THROMBIN INHIBITORS, THEIR PREPARING AND USE |
1993 |
- Neske-Jungblut Kristiane
- Shlojning Vol'F-Diter
- Alagon Alekhandro
- Possani Lourival'
- Kuehvas-Agirre Delia
- Donner Peter
- Khehndler Bernard
- Khekhler Ul'Rike
|
RU2183214C2 |
GLYCOPROTEIN VI AS COLLAGEN RECOMBINANT RECEPTOR ON PLATELETS AND ITS USING IN PHARMACEUTICS |
2000 |
|
RU2287580C2 |
THERAPEUTIC POLYPEPTIDES, HOMOLOGUES THEREOF, FRAGMENTS THEREOF AND APPLICATION THEREOF FOR MODULATION OF PLATELET-MEDIATED AGGREGATION |
2004 |
|
RU2524129C2 |
INHIBITORS FOR USING IN HEMOSTASIS AND IMMUNE FUNCTION |
2000 |
- Sheppard Pol O.
- Lehsser Dzherald U.
- Bishop Pol D.
|
RU2239449C2 |